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INTRODUCTION 
         Chronic Obstructive Pulmonary Disease (COPD) is defined as a disease 
state characterized by the presence of airflow obstruction due to chronic 
bronchitis or emphysema; airflow obstruction is generally progressive, may be 
accompanied by airway reactivity and may be partially reversible. 
Chronic Obstructive Pulmonary Disease (COPD) causes significant 
mortality and morbidity all over the world.  Death rate from the disease has 
increased in recent decades in apparent association with smoking and air 
pollution. 
Various synonyms for COPD 
1. Chronic Obstructive Airway Disease (COAD). 
2. Chronic Obstructive Lung Disease (COLD). 
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AIM OF THE STUDY 
1. To study various risk factors associated with Chronic Obstructive 
Pulmonary Disease (COPD). 
2. To evaluate biochemical, radiological, electrocardiographic, spirometric, 
Echocardiographic, ABG (Arterial Blood Gas) aspect of Chronic 
Obstructive Pulmonary Disease (COPD). 
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REVIEW OF THE LITERATURE 
         Chronic Obstructive Pulmonary Disease (COPD) has been defined by the 
Global Initiative for Chronic Obstructive Lung Diseases (GOLD) as a disease 
state characterized by airflow limitation that is not fully reversible1. 
         Chronic Obstructive Pulmonary Disease (COPD) is present only if 
chronic airflow obstruction occurs.  The definition excludes chronic bronchitis 
without chronic airflow obstruction.  Other causes of a chronic airflow 
obstruction such as cystic fibrosis, bronchiolitis obliterans and bronchiectasis, 
carcinoma of lung, chronic congestive heart failure1. 
         Chronic Obstructive Pulmonary Disease (COPD) may coexist with 
asthma and when abnormal airway reactivity is preexist, differentiation 
between these disorders can be challenging. 
         Chronic Obstructive Pulmonary Disease (COPD) comprises emphysema 
and chronic bronchitis, two direct processes, although most often present in 
combination. 
         Chronic bronchitis is defined as the presence of chronic productive cough 
for three months during each of two successive years in a patient in whom the 
other causes of chronic cough have been excluded2,3. 
         Emphysema defined as abnormal permanent enlargement of distal air 
spaces distal to terminal bronchioles, accompanied  by destruction of their 
walls and without obvious fibrosis3.  The pathological hallmarks of chronic 
obstructive pulmonary disease are inflammation of the small airways 
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(bronchiolitis)   and destruction of lung parenchyma (emphysema).  The 
functional consequences of these abnormalities is airflow limitation4,5. 
         The BTS(BritishThoracicSocietyguidelines) suggest that a diagnosis in 
clinical practice is usually associated with: 
1. A history of chronic progressive symptoms (cough, wheeze and / or 
breathlessness) with little variation. 
2. Usually a cigarette smoking history of greater than 20 pack year (1 pack 
year is equivalent to smoking 20 cigarettes a day for 1 year). 
3. Objective evidence of air ways obstruction, ideally by spirometry that 
does not return to normal with treatment. 
4. Chronic bronchitis has been classified into 3 form5. 
a. Simple bronchitis, defined as hyper secretion of mucus. 
b. Chronic or recurrent mucopurulent bronchitis in the presence of 
persistent or intermittent mucopurulent sputum. 
c. Chronic obstructive bronchitis when chronic sputum production is 
associated with airflow obstruction. 
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DIFFERENCE BETWEEN CHRONIC BRONCHITIS AND 
EMPHYSEMA 
TABLE : FISHMAN 
Clinical Hallmarks Predominant Bronchitis Predominant Emphysema 
1.  General Appearance Mesomorphic; over weight; 
dusky with suffused 
conjunctiva: warm 
extremities 
Thin, often 
emaciated, pursed 
lip breaths, 
anxious, prominent 
use of accessory 
muscle normal or 
cool extremities. 
2.  Age 40 – 55 50 – 75 
3.  Onset Cough Dyspnoea 
4.  Cyanosis Marked Slight to none 
5.  Sputum Copious Scanty 
6.  Breath sound Moderately diminished  Markedly 
diminished 
7.  Corpulmonale  Common Only during bout 
of respiratory 
infection and 
terminally 
8.  Radiograph Normal diaphragm position; 
cardiomegaly; lungs normal 
or with increased 
bronchovascular markings. 
Small pendulous 
heart; low flat 
diaphragms; areas 
of increased 
radiolucency 
9.  FEV1/VC Reduced Reduced 
10. FRC Mildly increased Markedly 
increased 
11. TLC Normal or slightly increased Considerably 
increased 
12. RV Moderately increased Markedly 
increased 
 
  
 
6  
BLUE BLOATER VERSUS PINK PUFFER 
 
                                                                                                                    
                                  
 
 
 
 
 
 
 
 
EPIDEMIOLOGY 
         Chronic Obstructive Pulmonary Disease (COPD) is a common medical 
problem which is worldwide in prevalence.  They are extremely common in 
India.  Here, they account for approximately 1/3 of patient seen in the chest 
clinic of general hospitals. 
         Disease is seen in mostly males over the age of 40 years who have been 
chronic and heavy smokers.  It may occasionally be seen in non-smoker who 
have been exposed to prolonged atmospheric pollution. 
Hypoxemia 
Hypercapni
Mixtures of chronic 
bronchitis and
Emphysema
Predominant 
bronchitis (“Blue 
Bloater” or “Type 
Predominant 
emphysema (“Pink 
Puffer” or 
Predominant cor 
pulmonale,  
right ventricular failure, 
Predominant dyspnea 
Near 
normal 
arterial 
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         An increased risk for the development of Chronic Obstructive Pulmonary 
Disease (COPD) in individuals of lower socio economic status, possible 
mechanism to explain the socio economic effect include crowded living 
conditional, increased incidence of Respiratory Tract Infections (RTIs).  
Nutritional status, birth weight and weight at one year of age are significant 
risk factors for later Chronic Obstructive Pulmonary Disease (COPD) and may 
be surrogate markers for socio economic status. 
         Feenstra et al, recently showed that there will be increase in burden of 
COPD between 1994 – 2015.  This will result in a 43% increase in prevalence 
of COPD for males and 42% increase for females52.  
RISK FACTORS 
TABLE 1 
RISK FACTORS FOR THE DEVELOPMENT OF CHRONIC 
OBSTRUCTIVE PULMONARY DISEASE (COPD) 
Host susceptibility 
Factors Environmental risk factors 
Age Smoking 
Airway responsiveness Occupational exposure 
Allergy (Indoor) Air pollution (wood smoke, chronic  
bio mass) 
Sex Diet 
Genetics Environmental allergens 
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- Risk considerations in Chronic Obstructive Pulmonary Disease 
(COPD) should be divided into (a) risk for disease development and 
(b) risk for disease progression. 
- Risk for disease development includes (Table 1) 
- Child-hood asthma and increased airways responsiveness may also 
represent the most important events that mark susceptibility for lung 
function decline and subsequent development of Chronic Obstructive 
Pulmonary Disease (COPD) 
- Asthmatic type symptoms tend to decline with lung growth. 
- Airway Hyper responsiveness, risk factor for both development and 
disease progression. 
1. Smoking 
         Cigarette smoking is the major risk factors associated with the 
development of Chronic Obstructive Pulmonary Disease (COPD).  All patients 
with chronically significant emphysema are smokers.  Heavy smokers are 
greater risk of developing Chronic Obstructive Pulmonary Disease (COPD) 
than moderate smokers6.  Passive smoking also seems to be harmful.  The rate 
of expiratory airflow in cigarette smokers, decreases twice as fast in smokers 
(40 ml a year) as in non-smokers.  (20 ml a year)6. 
         Cigarette smoking is clearly the single most important identifiable 
aetiological factor in Chronic Obstructive Pulmonary Disease (COPD).  
However, only 10 – 20% of smokers develop clinically significant Chronic 
Obstructive Pulmonary Disease (COPD) while approximately half never 
develop a clinically significant physiological deficit7. 
  
 
9  
         Factors involved in smoking related Chronic Obstructive Pulmonary 
Disease (COPD) includes: 
1. Genetic predisposition 
2. Female Sex 
3. Presence of underlying Asthma 
4. Airway responsiveness 
5. Possible, the presence of Allergy8 
         Although it is generally regarded as the dominant risk factor, cigarette 
smoking is not prerequisite in all definitions of Chronic Obstructive Pulmonary 
Disease (COPD) since COPD can occur in non-smokers such as patient with α1 
antitrypsin deficiency. 
         The effects of smoking cessation on mortality have been less clear.  
Randomized controlled trials fail to demonstrate a unequivocal benefit in terms 
of respiratory mortality from stopping smoking8. 
Passive Smoking or Second Hand Smoke (SHS) 
         Relationship between passive smoking and chronic airflow obstruction 
has been examined using case – control9 and a cohort study10,58.  These studies 
shows a trend towards an increased relative risk from passive smokers, similar 
to that of lung cancer but not powerful enough to demonstrate statistical 
significance.  SHS is a modifiable risk factor and it is determined with urine 4 
methyl nitrosamine, serum cotinine level in blood. 
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i. Current smoking defined as regular cigarette smoking ie. at least 
5 cigarettes a week almost every week for atleast 3 months serum 
cotinine level > 15 ng/ml.Previous smokers who denied current 
smoking with previously using cigarettes. 
ii. Never smoking with positive passive smoke exposure serum 
cotinine level < 15ng/ml. 
iii. Never smokers with negative passive smoking serum cotinine is 
usually undetectable. 
Passive smoking causes injury to respiratory system with the finding of 
combined increased mortality risk for men and women for COPD. 
Public health counselling, laws prohibiting public smoking is must for 
prevention of its hazards. 
2. Air Pollution 
         Several studies in 1950s, 1960s and early 1970s produced evidence 
incriminating air pollution as an etiological factor in COPD, including: 
i. The association, in the UK, between increasing mortality and prevalence 
of   COPD and increasing urbanization11. 
ii. The close association between atmospheric pollution and mortality from       
COPD both geographically and temporally12. 
iii. The demonstration that post office employees in foggy areas showed a      
higher rate of susceptibility than those working in less foggy areas13. 
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iv. The increased in reported symptoms of chronic bronchitis in areas of             
increased air pollution14. 
v. A higher prevalence of emphysema in autopsy studies in areas with 
greater pollution14. 
3. Occupation 
 It is generally accepted that there is a causal link between  occupational 
dust exposure and development of mucous hyper secretion15. 
         Chronic bronchitis is more prevalent in workers who engage in 
occupations exposing them to either inorganic or organic dust or to noxious 
gases. 
4. Genetics 
         Most COPD is not secondary to α1 antitrypsin deficiency, the only 
currently proven genetic risk for the diseases.  Instead, most COPD represents 
the expression of a complex genetic disease resulting from an interaction 
between host and environmental factors. 
5. Gender and Socio economic status 
 Most population studies have reported a higher prevalence of respiratory 
symptoms in men than in women10.  But the prevalence gap between male and 
female is narrowing due to increased rate of cigarette smoking in the last 20 – 
30 years.  Females are more susceptible to the effect of smoking than males 
since female have lower FEV1 than male. 
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ROLE OF INFECTIONS 
         Morbidity, mortality and frequency of acute respiratory infection are 
higher in patients with chronic bronchitis.  Epidemiologic studies implicate 
acute respiratory illness as one of the major factors associated with etiology 
and progression of COPD16. 
         Infections is a common precipitating factor, although only 50% of 
patients with severe exacerbation with associated respiratory failure have a 
positive sputum culture for a bacterium17.  The commonest organism are H. 
Influenezae and streptococcus pneumoniae17 although more recently moraxella 
catarrhalis has also been shown to be a common pathogen18.  However, patient 
with COPD are often chronically colonized with common bacterial pathogens 
and therefore culture of one of these organism during acute exacerbation does 
not imply that this organism is responsible for exacerbation.  Some studies 
have demonstrated an increased antibody titre of H.influenzae following 
exacerbation, suggesting that this organisms is causally involved19. 
         Viral infections have been shown to be responsible for up to 30% of all 
exacerbation of COPD.  This may well be an underestimate due to difficulties 
in viral isolation.  In view of relatively limited number of pathogen, it has been 
considered that bacteriological examination of the sputum may not influence 
the management in an acute exacerbation of COPD although this is 
controversial20,21,22. 
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PATHOGENESIS 
         COPD evolves from an inflammatory process involving the airways and 
distal airspaces.  The protease and antiprotease hypothesis holds that 
destruction of alveolar walls stems from an imbalance between protease and 
their inhibitors in the lung. 
The evidence is as follows23. 
i. Individuals with hereditary deficiency of the major protease inhibitor α-
1 antitrypsin, invariably develop emphysema and at a younger age if 
they smoke. 
ii.  Pulmonary instillation of proteolytic enzymes, includes neutrophil 
elastase, results in emphysema in experimental animals. 
Tobacco smoking contributes toemphysema by: 
1. Recruiting neutrophils into the lung by factors from smoke activated 
alveolar macrophages. 
2. Stimulating release of elastase from neutrophils. 
3. Enhancing macrophage elastase activity 
4. Inactivation of α 1 antitrypsin by oxidants in tobacco smoke or free 
radicals released by activated neutrophils. 
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SCHEMATIC REPRESENTATION OF THE EVOLUTION OF CHRONIC 
BRONCHITIS AND EMPHYSEMA 
 
 
Bronchospasm             
                                            Infection   
Hypersecretion           Occasional 
Of mucus          respiratory 
           infection 
   
Continued and                      Continued and     
Repeated injury                      repeated Infection   
(smoking)    
 
 
       Destruction                                    Continued and  
       Of alveolar          repeated injury                    Continued and 
       Walls         (smoking)                               repeated infection 
 
 
 
Bronchiolar and bronchial 
injury 
Destruction of alveolar 
walls 
Reversible obstruction in 
bronchioles and small 
bronchi 
Chronic bronchitis Emphysema 
Chronic bronchitis and 
emphysema 
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PATHOLOGY 
Emphysema 
         It is further classified according to the anatomic distribution of the lesion 
within the acinus23. 
1. Centri acinar Emphysema 
            It is characterized by 
a) Destruction and enlargement of the central or proximal parts of the 
respiratory unit – the acinus – sparing distal alveoli. 
b) Predominant involvement of upper lobes and apices.  Severe lesions are 
seen primarily in male smokes, often in association with chronic 
bronchitis. 
2. Pan acinar Emphysema 
           It is characterized by 
a) Uniform destruction and enlargement of the acinus 
b) Predominance of lower basal zones. 
c) Strong association with α1 – antitrypsin deficiency. 
3. Paraseptal Emphysema 
Paraseptal emphysema involves mostly the distal acinus sparing the 
proximal and:  
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a. Is found near the pleura and adjacent to fibrosis or scars. 
b. Is often the underlying lesion of spontaneous pneumothorax.      
4. Irregular emphysema 
         Irregular emphysema refers to irregular involvement of the acinus.  
usually asymptomatic. 
         Other types are bullous emphysema and interstitial emphysema. 
CHRONIC BRONCHITIS 
It is characterized by 
 Hyperemia and edema of mucous membrane of the lung 
 Mucinous secretion or cast filling airways. 
 Increase in size of the mucous glands 
 Bronchial or bronchiolar mucous plugging, inflammation and fibrosis. 
 Squamous metaplasia or dysplasia of bronchial epithelium. 
 Mucous gland hypertrophy can be quantified by the Reid Index23.  It is 
ratio of the thickness of submucosal glands to that of the bronchial wall. 
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Reid Index 
In person without chronic bronchitis    0.44 + 0.09 
In person with chronic bronchitis     0.52 + 0.08 
 
 
 
 
 
 
PATHOPHYSIOLOGY 
Airflow Limitation 
         Airflow limitation and increased airways resistance may be caused by 
loss of elastic recoil during passive exhalation due to emphysema by increased 
collapsibility of small airways through loss of radial traction on airways, or to 
increased resistance due to intrinsic narrowing of small airways. 
Impaired Gas Exchange 
         Maldistribution of inspired gas and blood flow is always present to some 
extent.  When the mismatching is severe, impairment of gas exchange is 
reflected in abnormalities of ABG.  Small airway narrowing causes a decrease 
in ventilation of their distal acinus. When alveolar capillaries remain intact, this 
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result in mismatching of ventilation and blood flow, reduced V/P ratio and mild 
to moderate hypoxemia, with emphysema, destruction of alveolar walls may 
decrease alveolar capillary perfusion as well, better preserving V/P matching 
and PaO2. 
Pulmonary Circulation 
         Pulmonary arterial hypertension develops late in the course of COPD, 
with the development of Hypoxiema  (PaO2 < 60 mmHg) and usually 
hypercapnia.  It is the major cardiovascular complication of COPD and is 
associated with RV Hypertrophy24 and with a poor prognosis in patient with 
COPD.    
Factors contributing to the development of pulmonary arterial 
hypertension 
1. Destruction of the pulmonary vascular bed. 
2. Abnormal blood gas tensions. 
3. Abnormal pulmonary mechanics. 
4. Increased cardiac output. 
5. Blood volume changes. 
6. Increased blood viscosity. 
7. Endothelial abnormalities. 
Renal and Hormonal Dysfunction 
         Chronic hypoxia and hypercapnia increase circulating levels of NE, 
Renin, aldosterone, AVP.  Renal arterial endothelium in COPD patient exhibits 
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defects similar to those seen in pulmonary arteries shunting blood flow from 
cortex to medulla and impairing renal functional reserve.  All these changes 
lead to salt and water loads and RV dysfunction. 
EFFECT OF COPD ON CARDIOVASCULAR SYSTEM 
         Chronic Obstructive Pulmonary Disease can contribute to cardiac disease 
by variety of mechanisms27,28,52. 
 
 
 
 
 
 
 
 
 
Lung Inflammation 
Chronic Acute 
Progressive 
Atherosclerosis 
Autonomic 
instability IL-6 GM-CSF 
Arrythymias Hypercoagulable 
State Neutrophil
TNF– 
C-reactive  protein 
Predisposing to 
Thrombosis 
Predispose to an 
inflammatory 
rupture of 
atheromatous 
plaques 
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(ii)     Functional interdependence 
         Patient with COPD likely stress their heart in number of ways both at rest 
and with exercise. 
Rest Changes in Lung Exercise Cardiac consequences 
↑ Lung 
Hyperinflation 
↑↑↑↑ -- 
↑ Work of breathing ↑↑↑↑ Need to deliver increased 
cardiac output 
Normal 
/ ↑ 
Intrathoracic 
pressure 
↑↑↑↑ Decreased venous return 
(Cardiac output) 
Normal 
/ ↑ 
Pulmonary 
Hypertension 
↑↑↑↑ Increased cardiac strain; 
limited increase cardiac 
output 
 
(iii)  Cardiac risk factors to consider in patients with COPD 
 Hypertension 
 Diabetes 
 Hypercholestrolemia 
 Renal Compromise ( GFR < 60 ml/mt) 
 Microalbuminemia  
 Obesity 
 Physical inactivity 
 Family History 
 Suggested lung assessment  
i. FEV1 
ii. FVC or FEV6 
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 Others 
i. Post bronchodilator FEV1 
ii. Lung Volumes 
iii. DLco 
iv. Exercise challenge (with or without bronchodilater)  
Reduction of Tachyponea, will lead to increase exercise tolerance, reduces the 
RA(Right Atrium) strain52. 
LABORATORY EVALUATION OF THE PATIENT WITH 
CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
HEMATOLOGY 
Red Blood Cells 
         Erythrocytosis is seen in certain patients with COPD, as well as in 
smokers without significant airflow obstruction.  A hematocrit at sea level 
about 52% in men and 47% in women warrants evaluation, because higher 
hematocrits are seen in less than 5% of normal individuals.  Upper normal 
limits for hemoglobin are 17.7g/dl for men and 15.7g/dl for women. 
         A normal red blood cell mass with a decreased plasma volume is 
characteristic of patients with relative (or) spurious erythrocytosis.  An 
increased red blood cell mass with a normal or decreased plasma volume is 
found in those patients with absolute (or) secondary erythrocytosis, which 
responds to discontinuation of smoking with oxygen therapy. 
  
 
22  
Classification of increased Hemoglobin or packed cell volume in the 
COPD patient 
Type of Erythrocytosis Examples 
1. Relative erythrocytosis 
(decreased plasma volume, 
normal red cell volume) 
Volume depletion – i.e. diuretic therapy, 
gastrointestinal disease, dehydration. 
Smokers polycythemia 
Chronic relative erythrocytosis 
2. Absolute erythrocytosis 
(or) 
Secondary Erythrocytosis 
1.  Appropriate Erythropoietin Secretion – 
i.e. High altitude, abnormal hemoglobin 
function, smokers’ polycythemia, 
Chronic Obstructive Pulmonary disease 
(COPD). 
   
2.  Inappropriate Erythropietin secretion – 
i.e. renal disease (Cysts, hypernephroma), 
cerebellar hemangioblastoma, hepatoma, 
etc.,  
3. Primary Erythrocytosis Idiopathic 
 
White Blood Cells 
         Leukocytosis in patients with COPD may result from either a 
complicating event (e.g. infection) or a therapeutic intervention (e.g. steroid 
therapy).  Blood and sputum eosioniphilia have been associated with a 
therapeutic response to steroid administration in some series. 
         Leukocytosis with a marked eosinophilia (> 300 mm3)  suggests a 
complicating disorder, such as allergic bronchopulmonary aspergillosis, 
eosinophilic pneumonia, Churg-Strauss vasculitis, or the hypereosinophilic 
syndrome. 
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Platelets 
         Patients with COPD and hypoxemia may demonstrate subtle 
abnormalities of platelet function.  Decreased platelet survival time, shortened 
regeneration time and increased platelet aggregation with elevations of the 
plasma beta-thromboglobulin level (an in vivo marker of platelet activation) 
have all been reported in hypoxemic COPD patients. 
CHEMISTRY 
Electrolytes 
         Hyponatremia in patients with COPD can arise in several different ways 
(mechanisms).  Complicating disorders such as lung tumors and pulmonary 
infection may produce hyponatremia by inappropriate secretion of antidiuretic 
hormone.  Most commonly, however, hyponatremia occurs as a result of salt 
and water retention. 
         A second electrolyte abnormality often seen in chronic obstructive 
pulmonary disease is hypokalemia.  Patients with hypokalemia are at increased 
risk for the occurrence of cardiac arrhythmias and respiratory muscle 
weakness.  Hypokalemia may be present in COPD patients as a result of oral 
intake, gastrointestinal loss from vomiting or diarrhea, or renal tubular defects 
with K+ wasting.   
         Hypophosphatemia is a frequent electrolyte abnormality in hospitalized 
patients with chronic obstructive pulmonary disease.  Hypophosphatemia 
usually results from a combination of insults. 
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         Hypomangesemia and hypocalcemia have also been associated with 
respiratory muscle weakness.  Although most frequently a complication of 
alcohol abuse, hypomagnesemia may also result from the frequent 
administration of diuretics. 
         The complete clinical implications of these electrolyte abnormalities have 
not been firmly established in the COPD patient.  The significant effect that 
electrolyte disturbances may have on respiratory muscle function, however, 
dictates close monitoring of these variables in the COPD patient. 
PULMONARY FUNCTION TEST 
         Although hundred of different types of disease can affect the lungs.  Only 
a few measurable pulmonary function derangement are found.  Identification of 
the physiological abnormalities present by using PFT narrow the list of 
possible causes of lung diseasae25. 
         Anatomic and physiological changes in the lungs occur early and remain 
clinically silent for many years.  Pulmonary functions are grossly abnormal in 
symptomatic patients26. 
         Ventilatory performances vary widely with body size, age and sex.  
Tables and nomograms are available which take these variables in to account 
and display predicted normal values for individuals of particular age and 
height. 
         The standard PFT used to measure airway obstruction is the forced 
expiratory spirometry. 
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         FEV1 is the volume of air expelled in the first second of maximal forced 
expiration from a position of full inspiration. 
         FVC is obtained by continuing forced expiration until no further air can 
be expelled. 
         Vital capacity is the volume of air expelled by a maximal expiration by a 
position of full inspiration. 
         The relationship between FEV1 and FVC is clinically very useful as it is 
to a large extent independent of body size and age. 
         FEV1 is reduced in any condition that reduces the vital capacity and when 
there is diffuse obstruction. 
         In forced expiration about 75% air is expelled in first second. 
         Tidal volume is the volume of air that enters and leaves the lung during 
normal breathing. 
INSPIRATORY RESERVE VOLUME 
         The maximum volume of Air that can be inspired after normal 
inspiration. 
EXPIRATION RESERVE VOLUME 
         Maximum volume that can be exhaled from the resting level. 
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RESIDUAL VOLUME 
         The volume of air still remaining in the lung after maximum volume of 
air that can be expelled from resting level. 
CHARACTERISTIC ABNORMAL LUNG FUNCTION IN 
OBSTRUCTIVE PULMONARY DISEASE 
1. Reduced FEV1, FVC and PEFR. 
2. Relatively greater reduction in FEV1, than FVC. 
3. Increased RV and RV/TLC ratio 
4. Uneven distribution of inspired gas 
5. Increased non elastic work of breathing 
6. Reduced PaO2 
7. Increased PaCO2 
8. Lowered arterial pH during exacerbation 
Chronic Respiratory failure : PaO2 < 60 mmHg 
    PaCO2 > 50 mmHg  
    While breathing are at sea levels 
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GOLD CRITERIA FOR COPD SERVERITY 
Gold 
Stage 
Severity Symptoms Spirometry 
0 At risk Chronic cough, sputum 
production 
N 
I Mild With less without chronic cough 
or sputum production 
FEV1/FVC < 0.7 and 
FEV1 > 80% 
predicted  
II Moderate With less without chronic cough 
or sputum production 
FEV1/FVC < 0.7 and 
50% < FEV1 < 80% 
predicted  
III Severe With less without chronic cough 
or sputum production 
FEV1/FVC < 0.7 and 
30% < FEV1 < 50% 
predicted  
IV Very 
severe 
With less without chronic cough 
or sputum production 
FEV1/FVC < 0.7 
FEV1 < 30% 
predicted (or) FEV1 
50% predicted plus 
chronic respiratory 
failure 
 
         An alternative way of looking at faced expiration is to measure both 
expiratory flow and volume exhaled plotting flow against volume to give a 
Maximum Expiratory Flow Volume curve (MEFV). 
Flow Volume Loops 
         Expiratory flows at 75% or 50% of VC have been used as a measure of 
airflow limitation and provide complementary information to the usual volume 
time plot.  There are problems with the reproducibility of these measurements, 
so that abnormal values must fall to below 50% of the predicted values.  Flows 
  
 
28  
at lung volumes less than 50% of VC were previously considered to be an 
indicator of small airways function but probably provide no more clinically 
useful information than measurements of FEV1.  Measurements of flow at fixed 
lung volumes are very variable in patients with COPD since volume calculated 
from flow at the mouth does not take account of thoracic gas compression 
during expiration.  The flow-volume loop in severe COPD shows a relatively 
preserved PEF followed by a rapid decrease in flow after the first 200 – 300 ml, 
as airways collapse. 
         PEF can either be read directly from the flow – volume loop measured 
with a hand-held peak flow meter.  The hand held instruments are relatively 
easy to use and are particularly useful for repeated measurements in asthmatics, 
since serial measurements during exacerbations or at home can reveal 
variations in response to therapy or spontaneous diurnal variability.  However, 
in COPD there is little daily change in PEF and many variations are often 
within the error of the measurement.  Although repeated measurements of PEF 
can be used in place of FEV1 single measurements are not useful as the 
variation is so high.  There are several theoretical reasons why FEV1 is a better 
test than PEF in the diagnosis and assessment of COPD, so that PEF is an 
inferior measurement of airways obstruction in COPD. 
The reasons why FEV1 recommended as the measurements of choice in 
COPD 
 The FEV1 is a reproducible and objective measurement.  There are well-
defined normal ranges that allow for the effects of age, race and sex. 
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 It is relatively simple and quick to measure and can be measured at all 
stages of diseases. 
 The forced expiratory manoevure records not only FEV1 but also FVC.  
An FEV1/FVC ratio less than 70% is diagnostic of airways obstruction.  If 
the ration is normal (>70%) and the test was performed well, the pattern is 
not obstructive and the diagnosis is not COPD. 
 PEF measurements cannot determine whether values are low because of 
obstruction or restriction. 
 The variance of repeated measurements in the same person is well 
documented and is low studies of mortality and disability have shown that 
the FEV1 predicts future mortality. 
 Serial measurements provide evidence of disease progression. 
 In COPD the relationship between PEF and FEV1 is poor. 
 PEF may underestimate the degree of airways obstruction in COPD. 
Gas Transfer for Carbon Monoxide 
         DLco values are below normal in many patients with COPD and although 
there is a relationship between DLco and the presence of microscopic 
emphysema, the severity of the emphysema in an individual patient cannot be 
predicted from the DLco.  Neither is a low DLco specific for emphysema.  
Thus a low DLco is suggestive of a significant degree of alveolar destruction, 
probably as a result of emphysema, although a normal DLco does not exclude a 
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diagnosis of COPD.  The methodology to assess DLco may also influence the 
result in patients with COPD.  The method of Ogilvie and colleagues measures 
the rate of carbon monoxide uptake during a 10s breath hold and related this to 
the alveolar volume, derived by adding the inspired volume to the RV 
measured in a separate helium dilution test.  Now, more widely used method is 
the single breath technique, which uses alveolar volume calculated from helium 
dilution during the single breath test.  This underestimated alveolar volume in 
patients with severe COPD, producing a lower value for DLco. 
Arterial blood gases 
         Measurement of arterial blood gases is essential in patients with COPD to 
confirm the degree of hypoxemia and hypercapnia and, in acute exacerbations 
particularly, to determine the hydrogen ion concentration.  It is recommended 
in patients with an FEV1 < 40% of their predicted value.  It is essential to 
record the inspired oxygen concentration when reporting blood gases, and it is 
also important to note that it may take at least 30 min for a change in inspired 
oxygen concentration to have its full effect on the PaO2 because of long time 
constants for alveolar gas equilibration in COPD. 
         Pulse oximetry and transcutaneous oxygen tension measurements are 
increasingly used in intensive care units.  They can be useful in measuring 
changes in oxygenation during an acute exacerbation of COPD, sleep, and 
activities.  However, they should not replace an assessment of blood gas 
tensions, since measurements of PaCO2 are often required. 
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         Acid-base status can also be assessed from the arterial pH (hydrogen ion 
concentration) and bicarbonate concentration.  From the modified Henderson – 
Hasselbalch equation, (H+) = kxPaCO2 / (HCO3-) where (H+) is the hydrogen 
ion concentration, K a constant and [HCO3-] the bicarbonate concentration, 
increases in PaCO2, which can occur rapidly, can be compensated by renal 
conservation of bicarbonate, a relatively slow process.  Acid-base status, 
particularly mixed respiratory and metabolic disturbances, can be characterized 
by plotting values on an acid-base diagram [559].  Such a diagram is useful in 
apportioning the relative contributions of primary respiratory and metabolic 
causes of the acid-base disturbance and, when serial values are plotted, the 
response to treatment. 
         In COPD of mild to moderate severity Hypoxemia typically occurs 
without Hypercapnea.  In severe COPD, CO2 retension and severe hypoxemia 
occurs severity of arterial desaturation more in blue bloaters than pink puffers.  
Episodes of nocturnal desaturation associated with worsening of pulmonary 
hypertension. 
         In nomenclature of acid base disorders PH, PaCO2, HCO3 (bicarbonate) 
are considered.  PaCO2 values are normally kept within narrow limits by the 
respiratory centre, and the Chemo receptors located in the medulla, close to 
floor of 4th ventricle and in caroid.  These receptors are suppressed by chronic 
Hypoxia, Hypercapnea, secondary to alveolar hypoventilation. 
         Respiratory acidosis is frequently associated with COPD; Respiratory 
alkalosis encountered in patient on diuretic therapy, transient hyperventilation. 
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Reversibility to Bronchodilators 
         The American, European and British Thoracic Societies (ATS, ERS and 
BTS) recognize that assessment of reversibility to bronchodilators is an 
essential part of the investigation and management of patients with COPD.  
Reversibility tests are important in COPD for several reasons:  (a)  to help 
distinguish those patients with marked reversibility who have underlying 
asthma. (b)  because the FEV1 after bronchodilator is the best predictor of 
survival.  However, there is no agreement on a standardized method of 
assessing reversibility.  Reversibility is usually assessed by measuring changes 
in FEV1 or PEF but could also be determined as a change in static lung 
volumes after bronchodilators, which may explain why some patients have 
improvement in symptoms with little spirometric change following a 
bronchodilator. 
ELECTROCARDIOGRAPHIC FEATURES 
         COPD influence the electrical events of the heart in the following 
respects. 
1. The voluminous lungs have an insulating effect and there by diminish the 
transmission of electrical potentials to the registering electrodes. 
2. The heart descends to a lower position within the thorax due to lowering 
of the diaphragm.  This will alter the position of the heart relative to the 
conventional precordial electrode position. 
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3. RV and RA become compromised due to reduction of pulmonary 
vasacular bed.  This will result in RVH and dilatation as well as RA 
enlargement. 
ECG pattern are influenced by many factors such as PAP, pulmonary 
vascular resistance, rotation and displacement of heart by hyper inflated lungs, 
ABG, myocardial ischemia and metabolic dysfunction27. 
The voluminous lungs impair electrical transmission causing marked 
diminution of QRS and T waves. 
The loss of r or R wave amplitude in the precordial leads are attributed to 
a) Low anatomic position of heart 
b) Inferiorly and posteriorly directed QRS axis 
         Right atrial enlargement is manifested by right ward deviation of ‘p’ 
wave axis and characteristics ‘P’ pulmonale. 
         Frontal plane QRS axis is usually deviated to the right. 
         Schaffer et al29 found that 5% patient with COPD had LAD, while 9% 
had dominant ‘S’ wave in the three standard leads (S1S11S111 syndrome). 
         The single most characteristic of COPD is said to be a ‘P’ wave axis 
between +70 and +90o. 
         There may be complete and incomplete RBBB. 
  
 
34  
         The presence of RV hypertrophy is mostly reflected by (a) RAD, (b) 
Prominent terminal S waves in left precordial leads, (c) in advanced case of 
PHT, the R waves may become inverted in the magnitude in (Rt) precordial 
leads. 
         Fishman anoted that30 the standard criteria for RV enlargement were 
absent in 2/3rd of patient with COPD who had RVH on post mortem 
         It has been suggested that where classical RVH changes are absent, 
diagnosis be based on combination of30. 
a. rs in V5 V6 
b. RAD 
c. QR in a VR 
d. `P' pulmonale 
Most frequent arrhythmia seen is multifocal artrial tachycardia. 
COPD can produce changes in the ECG that mimic MI.  A marked 
reduction or even total absence of anterior QRS forces are most common 
observation result. 
         In small r wave or QS complex in precordial lead V1 – V4. 
         If there is additional RVH or acute RV dilatation, T wave become 
inverted in these leads further mimicking MI.  Abnormal Q wave or QS 
complexes can be recorded in leads AVF or Lead I thus mimicking inferior 
wall (or) lateral wall infarction.  If the diagnosis of COPD is known, any ECG 
showing those features should not be interpreted as showing MI unless there is 
clinical correlation. 
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         The electrocardiogram (ECG) is abnormal in approximately 75% of 
patients with significant obstructive airway disease.  The characteristic ECG 
findings in these patients are summarized.  Although none of the individual 
criteria is specific, the simultaneous finding of characteristic P wave and QRS 
changes strongly supports the presence of underlying COPD. 
Electrocardiographic changes in Chronic Obstructive Pulmonary Disease 
ECG  
Changes 
Characteristics 
P wave Right ward deviation of the p wave axis; ‘p’ wave > 2.5 mm in 
leads II, III, aVF; prominent negative ‘p’ wave in lead I 
QRS Tendency for right axis deviation of the QRS vector and marked 
clockwise rotation of the electrical axis; QRS amplitude in all limb 
leads < 5 mm; QRS amplitude < 5mm in leads V5 and / or V6, or R 
wave < 7mm in leads V5 or R wave < 5mm in V6, R to S ratio < 1 
in leads V5 and / or V6;  R to S amplitude ratio in V1 < 1; S1Q3 or 
S1S2S3 pattern with R to S ratio < 1 in leads I, II and III; 
incomplete (and, rarely) complete right bundle branch block. 
Other Lead I sign with isoelectric P wave, QRS amplitude less than 1.5 
and T wave amplitude less than 0.5 mm; pseudoinfarction pattern 
with large Q waves or QS in the inferior or precordial leads. 
 
         The more vertical P wave axis, characteristic of patients with significant 
airflow obstruction, results in the biphasic or isoelectic P wave in lead I and / or 
a V1.  This shift of the P wave axis correlates with the severity of the airflow 
obstruction in some series.  P pulmonale, characterized by peaked P waves 
(greater than 2.5 mm) in the inferior leads, occurs in patients with more severe 
airflow obstruction. 
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         The QRS axis is shifted to the right, usually by less than +900.  This shift 
of the QRS axis may be associated with an S1S2S3 pattern.  The orientation of 
the mean QRS axis posteriorly, superioly, and to the right can result in an 
‘apparent’ left axis deviation.  An S2 greater than S3 to distinguish this finding 
from true left axis deviation. 
         Wasserburg and colleagues have observed  an electrocardiographic 
pattern, termed the “pentology  of pulmonary emphysema” in patients with 
advanced emphysema.  This pattern consists of the following:  (1) Exaggerated 
P waves in leads II, III and aVf  (2) prominent T-a waves in leads II, III and aVf  
(3) vertical cardiac position, which at times may be extreme; (4) clockwise 
rotation on the longitudinal cardiac axis; and (5) tendency to low voltage, 
particularly in the left ventricular leads. 
         Kok-Jensen studied the ECG features of 228 patients with chronic 
bronchial obstructions.  A decreased survival was seen in patients with a QRS 
axis of +900 to 1800 and a p-wave amplitude in lead II of 0.20 mV or greater; 
only 37% and 42%, respectively, of the patients with these features were alive 
at 4 years.  Smit and colleagues found that  a higher P-wave amplitude in lead 
II and / or S amplitude in lead V6 was associated with a decreased 5-year 
survival.   
Sputum Analysis 
         Cellular analysis of the sputum can be helpful in the evaluation of 
patients with COPD.  Macroscopic examination of sputum is often misleading, 
because both neutrophil and eosinophills produce purulent sputum.  Medici and 
  
 
37  
Collegues have suggested that the sputum of patients with chronic bronchitis 
undergoes three phases; a stable phase, an infectious phase and a resolution or 
post infection phase.  During acute exacerbations, sputum neutriphils and 
bronchial epithelial cells increase.  The bronchial epithelial cells remain 
elevated in the post infectious phase, whereas the neutrophils decrease to stable 
phase levels.  Alveolar macrophages, which do not increase during the 
infectious phase, increase significantly during the resolution period. 
         A wet preparation of the sputum or an appropriately stained specimen 
allows detailed analysis of the cellular elements (alveolar macrophages, 
neutrophils and eosinophils).  The cellular analysis helps to determine the 
adequacy of the sputum specimens and to distinguish between an infectious 
exacerbation characterized by a neutrophilic predominance and an allergic 
exacerbation characterized by an eosinophilic predominance (occasionally 
associated with Curschmann’s spirals and charcot-Leyden crystals). 
         Diplococcus pneumoniae and Hemophilus influenzae are the most 
common bacterial organisms isolated from patients with increased production 
of purulent sputum.  They are also found as regular inhabitants of the upper 
respiratory tract of normal individuals.  In addition, they are frequently present 
in the tracheobronchial secretions of asymptomatic COPD patients.  Therefore, 
the significance of isolating these organisms in the COPD patient with chronic 
bronchitis and purulent sputum, even with “adequate” specimens, is unclear.  
Transtracheal aspiration represents an alternative technique for obtaining 
specimens of tracheobronchial secretions for bacteriologic evolution in the 
COPD patient.  The technique involves the insertion of a needle catheter 
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system through the cricothyroid membrane with aspiration of tracheobronchial 
secretions.  Transtracheal aspiration should only be carried out by trained 
personnel because of the increased risk of complications associated with the 
techniques, such as bleeding, infection and subcutaneous emphysema. 
         Although generally recognized to be more reliable than expectorated 
sputum, interpretation of the results of cultures of transtracheal aspirates in 
patients with chronic lung disease is again limited as a result of a high 
incidence (86%) of positive cultures, even in clinically stable patients.  
Schreiner and colleagues, using transtracheal aspirates in 76 patients with 
chronic sputum production, found that 80% of the aspirates in 76 patients with 
chronic sputum production, found that 80% of the aspirates grew Hemophilus 
influenzae or Diplococcus pneumoniae31.  Haas and associates, studying 
patients with chronic bronchitis, compared three methods for the evaluation of 
tracheobronchial secretions in patients with chronic sputum production; 
oropharyngeal sampling, transtracheal aspiration, and bronchoscopy.  They 
found a high degree of correlation in the culture results using all three 
techniques.  As expected, patients with chronic bronchitis most commonly 
grew H. influenzae and D.neumoniae, regardless of the sampling method. 
         Finally, bronchoscopy and related techniques, inlcuidng transbronchial 
lung biopsy, protected catheter brush specimens, and bronchoalveolar lavage, 
are available for the evaluation of infection in the COPD patients.  Because of 
the increased risk of morbidity and mortality with these procedures, they are 
generally reserved for the COPD patient with undiagnosed pneumonia or for 
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the immunocompromised host.  The risks and benefits of these techniques have 
been reviewed elsewhere. 
         Despite the many techniques available for sputum analysis of the COPD 
patient, the most appropriate indications and technique for microbiologic 
analysis have yet to be determined.  The consistence isolation of identical 
organisms, regardless of the sampling technique or clinical status of the patient, 
has prompted some clinicians to conclude that sputum microbiologic evolution 
in the absence of pneumonia is unrewarding. 
         In addition to microbiologic criteria, biochemical characteristics of 
sputum have been proposed for the evaluation of COPD patients.  
Inflammatory bronchial secretions may contain elevated levels of 
deoxyribonucleic acid (DNA0, lacate dehydrogenase (LDH), fibrinogen, and 
albumin.  Shockely and colleagues have suggested that levels of 11S (locally 
produced) and 7S (Serum-derived)  IgA are increased in infectious sputum.  In 
addition, the free secretory piece of IgA seen in noninfected sputum is 
apparently absent in infected specimens.  The value of these biochemical 
parameters in the evaluation and treatment of patients with COPD remains to 
be determined. 
         Other proteins such as albumin, the immunoglobulins, transferring, AAT, 
alpha2 – macroglobulin and alpha1 – antichymotrypsin may also be present.  
Under conditions of chronic bronchial irritation, these proteins may exist in a 
partially fragmented or denatured form.  Albumin and AAT appear to enter 
lung secretions by passive diffusion, whereas alpha1 – antichymotrypsin and 
alphs2 – macroglobulin are secreted locally. 
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Corpulmonale 
         Pulmonary Heart Disease (i.e. corpulmonale) refers to cardiac 
dysfunction resulting from altered structure or function of lung.  Since lungs 
are interposed in the cardiovascular circuit between the Right Ventricle (RV) 
and left side of the heart.  Alterations in lung structure or function will 
selectively affect the right side of the heart, most often result from COPD.  
World Health Organization defined chronic corpulmonale as “Hypertropy, with 
eventual dilatation of right ventricle resulting from disease affecting the 
function and / or structure of lung, except when these pulmonary alterations are 
the result of disease that primarily affect the left side of the heart or congenital 
heart disease.  Acute corpulmonale is a disorder in which right ventricle is 
dilated and muscular wall is stretched and thin.  Most often result from 
pulmonary embolism27,34. 
         In Delhi, India, where a large segment of population lives under 
conditions of severe air pollution and incidence of corpulmonale estimated to 
be 16%, less common causes of corpulmonale are diffuse interstitial lung 
disease, tuberculosis with extensive destruction of parenchyma and 
conglomerate fibrosis, sleep apnoea syndrome.   
         Common predisposing factors for corpulmonale are arterial hypoxemia, 
respiratory acidosis which leads to pulmonary hypertension (PH) and 
corpulmonale.  Generally, up to 14% of patients with COPD suffering from 
secondary pulmonary hypertension. 
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         The diagnosis is generally based on electrocardiographic criteria.  The 
classic determinant of RVH, developed from patient with congenital heart 
disease; includes (i) a right axis shift of QRS (> 110); (ii) an R to S ratio in V1 
> 1 and (iii) a R to S ratio in V6 < 1.  However, these have proven to be 
relatively poor criteria for diagnosis of corpulmonale in patient with COPD. 
         Some electrocardiographic findings may be seen in patients with 
emphysema in the absence of right ventricular hypertrophy (RVH).  These 
involve ‘p’ pulmonale; S1, S2, S3 pattern, and the left ward shift of the 
transitional zone. 
         The presence of (i) RSR or QR pattern in V1 (ii)  marked clockwise 
rotation of electrical axis (iii)  a frontal plane QRS of 110o or more (iv) large Q 
waves or QS waves in inferior, mid precordial leads (v) ST, T changes right 
precordial or inferior leads are more suggestive of RVH in those with COPD. 
         Kilcoyne and associates have suggested progressive change in ECG 
occurs in response to hypoxemia arterial saturation of < 80% and mean 
pulmonary artery pressure 25 or more. 
         These changes consists of: 
    1.  Inverted, biphasic or flattened ‘T’ waves in the right precordium. 
    2. Mean electrical axis of QRS shift 30o or more to right side of the patient’s 
usual axis.  
    3.  ST segment become depressed in lead II, III, aVF 
4. RBBB complete or incomplete 
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         These abnormality frequently variable with degree of hypoxemia.  If 
pulmonary hypertension persisted, the right ward rotation of the QRS axis and 
the ‘T’ wave changes in the right precordial leads remained.  
         If pulmonary function was not reversed with therapy, the true right axis 
deviation (a frontal plan axis > 90o) and increased R wave voltage in the right 
precordial leads developed.  These abnormalities tended to be non-reversible. 
         The classic view of the development of right ventricular hypertrophy 
(RVH) in patients with COPD is that reduction of pulmonary vascular bed and 
hypoxia induced pulmonary vasoconstriction, increased pulmonary vascular 
resistance, leading to pulmonary hypertension. 
Non invasive techniques 
         Non-invasive techniques, such as echocardiography, radio nudeotide 
imaging, HRCT, MRI are used to confirm the diagnosis of pulmonary 
hypertension complicating COPD.  M-Mode echocardiography is of limited 
usefulness because the hyperinflation of the chest that occurs with COPD 
interferes with adequate visualization of the right ventricle.   
         Two-dimensional echocardiography (2D echo), however, permit 
visualization of both right ventricular chamber and pulmonary artery 
dimensions.  The Echocardiographic parameters of pulmonary hypertension 
includes analysis of motion of pulmonary valve, right ventricular anterior wall 
thickness, pulmonary artery size, right sided systolic time interval ratio and the 
slope of the contrast echoes through pulmonary valve. 
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         Limitations in the use of echocardiography to assess the status of 
pulmonary hypertension are poor penetration of ultrasound in these patients 
particularly in patient with emphysematous changes. 
         The systolic pulmonary artery pressure could be estimated accurately 
with continous wave Doppler ultrasound (CWD) from the peak velocity of a 
TR jet. 
         MRI helps to assess right ventricle (RV), left ventricle (LV) mass, end 
diastolic volume (after the R-wave of ECG), ejection fraction (EF).  Marked 
RV hypertrophy accompanied decreased RV end diastolic volume.  The 
hypertrophy is classified as concentric type and is consistent with radiological 
characteristics of emphysema i.e., patients with narrow vertical heart. Increased 
RV dimensional seen with severe COPD patients. 
         The adequacy of radio nudeotide investigation of the heart with thallium 
– 201 imaging depends on the muscle wall and the blood flow to the organ to 
allow visualization.  The non-dominant right ventricle is usually not visualized 
in most patients studied with this technique.  The right ventricle of patients 
with COPD shows right ventricular enlargement and / or hypertrophy. Right 
ventricular visualization with thallium – 201 imaging suggest the presence of 
pulmonary hypertension.  Measurement of right ventricular ejection fraction by 
radio medeotide imaging may be another useful test for the non-invasive 
diagnosis of pulmonary hypertension in COPD. 
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Prognosis of COPD 
         COPD has variable natural history.  It is not having specific indicators to 
grade the severity.  Spirometry has definitive role in assessing the severity 
prognosis inversely related to age and directly related to post bronchodilator 
FEV1.  BODE scoring helps in assessing the mortality rate at 52 months which 
includes body mass index (BMI) obstruction (FEV1 % predicted), Dyspnoea, 
exercise, score of 0 – 2 caused 10%; 7 – 10 causes 80% mortality rate at 52 
months. 
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MATERIALS AND METHODS 
         50 patients attending outpatient department in Government Stanley 
Hospital during the period of November 2006 – June 2007 were studied. 
Inclusion Criteria 
1. All patient with chronic obstruction airway disease whose FEV1 less 
than 70% of total FVC. 
Criteria for chronic bronchitis 
a. History of chronic cough with exacerbation followed by 
breathlessness. 
b. Clinical examination showing diffuse crepitation and ronchi in both 
lung fields. 
 Criteria for emphysema 
a. History of chronic breathlessness with recent onset of cough with 
expectoration. 
b. Clinical examination showing increased AP diameter, diminished 
chest expansion, Hyper resonant note on percussion, decreased 
cardiac dullness, elicitation of hepatic dullness at a lower plane and 
dinished vocal fremites, vocal resonance, breath sound. 
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c. Radiologically 
i. Flattening of diaphragmatic domes  
ii. Long and narrow cardiac silhouette 
iii. Increased translucency and widening of intercostals 
spaces. 
Patient in acute exacerbations 
1. Worsening of cough and sputum production 
2. Worsening of breathlessness 
3. Change in colour of sputum 
         Patient with age group of 22 – 86 years with duration of illness ranging 
from one to fifteen years at different stages of disease were studied. 
Exclusion criteria 
1. All cases with pneumonia or bronchiectasis on chest x ray 
2. HIV positive patient 
3. Patient with lung malignancy 
4. Acute pulmonary tuberculosis 
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RESULTS 
¾ The study included 50 patients of age 22 – 86 years 
¾ Among these, 30 patients belonged to Emphysema, 20 belonged 
to chronic bronchitis group. 
¾ Although most patients have combination of both group. 
AGE WISE DISTRIBUTION OF THE ABOVE PATIENTS 
Age Chronic bronchitis Emphysema Total Percentage 
< 40 2 0 2 4% 
41 – 50 6 8 14 28% 
51 –60 8 16 24 48% 
61 – 70 2 4 6 12% 
71 – 80 2 1 3 6% 
> 80 years 0 1 1 2% 
 
SEX WISE DISTRIBUTION OF THE  PATIENTS 
Sex  Chronic bronchitis Emphysema Total Percentage 
Male 18 30 48 96% 
Female 2 0 2 4% 
 
         In this study, most of the patients with COPD were only males. 
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DISTRIBUTION OF PATIENTS ACCORDING TO SOCIO ECONOMIC 
STATUS 
Socio Economic status Total Percentage 
High 2 4% 
Intermediate 10 20% 
Low 38 26% 
 
HISTORY OF SMOKING AMONG 50 PATIENTS OF COPD 
Smoking 
History 
Chronic 
bronchitis 
Emphysema Total Percentage 
Moderate 
smokers 
8 12 20 40% 
Chain smokers 8 16 24 48% 
Non Smokers 4 2 6 12% 
 
88% of patients with COPD were past smokers.  Only 12% were non smokers. 
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FAMILY HISTORY OF COPD 
Family History 
Chronic 
bronchitis 
Emphysema Total Percentage 
Present 6 0 6 12% 
Absent 14 30 44 88% 
 
Family History of Obstructive airway disease present only in 12% patients. 
SPIROMETRIC EVALUATION OF PATIENTS WITH COPD 
FEV1 of 
predicted 
Chronic 
bronchitis 
Emphysema Total Percentage
50 – 80% 3 6 9 18% 
30 – 49% 10 16 26 52% 
< 30% 7 8 15 30% 
 
Majority of patients 52% had FEV1% of predicted is 30 – 49%. 
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CHEST X-RAY FINDING AMONG 50 PATIENTS 
 
X-ray changes Chronic bronchitis Emphysema Total Percentage 
Emphysematous 
changes 
2 26 28 56% 
Increased 
broncho vascular 
markings 
16 4 20 40% 
Cardiomegaly 1 0 1 2% 
PAH 
(Rt.decending 
pulmonary artery 
> 16 mm) 
1 0 1 2% 
 
ECG FINDINGS AMONG 50 PATIENTS 
ECG Changes 
Chronic 
bronchitis 
Emphysema Total Percentage 
1.‘p’ wave  > 2.5 mm 10 12 22 44% 
2. QRS axis > 90 6 7 13 26% 
3. ‘R’ wave in V1 > 7  
     mm (or) R/S in V1 > 1 
6 3 9 18% 
4. R/S in V5 < 1 5 8 13 26% 
5. RV strain 6 3 9 18% 
6. RBBB 2 1 3 6% 
7. Poor ‘R’ wave progression 3 8 11 22% 
8. LI sign 2 4 6 12% 
9. QRS in limb leads < 0.5 mv 6 8 14 28% 
10.MAT 3 2 5 10% 
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ARTERIAL BLOOD GAS CHANGES (ABG) AMONG 50 PATIENTS 
ABG Changes Total No. of Patients Percentage 
Normal 45 90% 
Respiratory Acidosis 5 10% 
Respiratory alkalosis 0 0% 
 
ECHOCARDIOGRAPHIC CHANGES AMONG 50 PATIENTS 
Echo changes Total No. of patients Percentage 
PH -- 0% 
RV dilation with pulmonary 
Hypertension (PH) 
2 4% 
Normal 48 96% 
 
CORRELATIVE ANALYSIS OF ABG, ECHOCARDIOGRAPHY, 
SPIROMETRY 
FEV1 Respiratory acidosis RV dilatation 
50 – 80% -- -- 
30 – 49% 2 1 
< 30% 3 2 
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DISCUSSION 
         In this study of 50 patients with COPD; 30 (60%) patients belonged to a 
group with predominant emphysema feature.  20 patients (40%) belonged to 
the predominant chronic bronchitis feature even though in some of the above 
patient there was overlap between the two group having a mixed features. 
AGE 
         They all belonged to different age groups.  Mostly they were between 40 
to 80 years. 
         Highest age  → 86 years 
         Lowest age  → 22 years 
         Commonest age group according to various studies is between middle 
and late adult life31. 
         In India, the disease is mostly enumarated in males over 40 years who 
have been chronic and heavy smoker26. 
         Increasing age is an important risk factor but it has not been possible to 
prove that this is the result of aging perse rather than cumulative effect of 
explosive to environmental stresses32. 
         In this study COPD is mostly seen from 4th to 6th decade. 
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SEX INCIDENCE 
         Regarding sex incidence, males are more affected than female. 
         In this study, 96% case were male this is in according with the world 
literature31 COPD is not common in female32. 
         Male preponderance was probably due to the repeated explosive  smoking 
habits and atmospheric pollution.  However, the incidence of COPD had been 
said to be increasing in female also in West. 
SOCIO ECONOMIC STATUS 
         There is no single classification of socio economic status.  In our study 
patients were divided into 3 groups based on occupation. 
    1.  High - Professionals 
    2.  Intermediate - Partial skilled occupations 
    3.  Low - Unskilled occupational 
         In our study, most of the patients (76%) belong to low socio economic 
status.  It is likely that the effect of socio economic status is mediated by 
associated factors such ass over crowding, frequency of respiratory illness, 
nutrition, availability of medical care, etc., Socio economic status appears 
important in some studies but not in others.  Hence, socio economic status 
might be considered as additional provocative factor than an inherent risk 
factor of COPD45. 
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SMOKING 
         History of smoking elicited.  Excluding female almost all makes gave a 
history of chronic smoking either cigarette or beedi.  They were divided into: 
    1.  Moderate smokers   → > 10/day for > 10 years 
    2.  Chain smokers → 20/day for > 15 years 
         In our study COPD was present only 6 non smokers (12%).  Of these, 2 
of them were females.  Although cigarette smoking is generally regarded as the 
dominant risk factor.  Cigarette smoking is not a prerequisite in all definition of 
COPD, since COPD can occur in non smokers34. 
FAMILY HISTORY 
         In this study, 6 patients give family history of wheezing (12%).  These 
patients have feature of Asthma with feature of chronic bronchitis.  Although 
COPD patients were divided into chronic bronchitis and emphysema some 
patients have features with Asthma.  They were classified as a group called 
asthmatic bronchitis6.  According to one study familial tendency does not 
appear to be an important risk factor for airway obstructive diseases35. 
SPIROMETRY 
         FEV1 / FVC ratio is grossly reduced in-patient suffering from chronic 
bronchitis.  These patients were divided into various severities by GOLD 
CRITERIA2 according to FEV1 as a percentage of predicted value. 
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                    Severity             FEV1% Predicted 
           i.       Mild     50 – 80% 
          ii.       Moderate     30 – 49% 
        iii.        Severe     < 30% 
         In this study, most patients (82%) have FEV1 / FVC ratio of < 50%.  This 
is in accordance with the principle most patients become symptomatic only 
when FEV1 falls below 50%2. 
CHEST X RAY FINDING  
         In our study, a total of 28 patients showed emphysematous change, which 
consist of low flattened diaphragm, decreased vascularity in the periphery of 
lung, tubular heart36,37.  In this 28 patient 2 belonged to chronic bronchitis 
group.  The accuracy of diagnosis emphysema on the plain chest film increased 
with severity of disease and has been reported as being 50 – 80% accurate in 
patients with moderate to severe disease36.  However, the sensitivity has been 
reported as being as low as 24% in patient with mild to moderate disease. 
         20 patients showed increased bronchovascular marking most of them 
were predominantly of chronic bronchitis group.  Here increased 
bronchovascular markings means they could be seen up to the periphery of 
lung field with a coarser appearance.  1 patient showed radiographic evidence 
of pulmonary – artery hypertension evidenced by diameter of right descending 
pulmonary artery greater than 16 mm38. 
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         One patient showed cardiomegaly. These patient was carefully screened 
for coexisting condition like systemic hypertension and valvular heart disease.  
However, such condition were not present in the above mentioned one patient 
with prominent chronic bronchitis features.  So, cardiomegaly may be probably 
due to gross enlargement and clockwise rotation of right ventricle. 
ECG CHANGES   
         The single most characteristic ECG feature is ‘p’ wave axis between +70 
- +90 and ‘p’ wave amplitude > 2.5 mm39.   
         In our study, both these changes were present in 44% of patients 
respectively.  Patient with ‘p’ pulmonale also exhibited marked reduction in 
FEV1 ratio below 50%42. 
         KDK – Jensea studied the ECG features of 228 patients with chronic 
bronchial obstruction.  A decrease survival was seen in patients with a QRS 
axis of +90 and  + 180 and ‘p’ wave amplitude in lead II of 0.2 MV or greater. 
         Frequently instead of full blown pattern of RV hypertrophy and strain 
with tall ‘R’ waves in V1 an intermediate pattern is seen with deep ‘S’ waves 
across the precordial leads V1 – V24.  rS pattern in the chest leads corresponds 
with a large posteriorly directed portion of the horizontal vector loop (Walsh et 
al 1960) and is clearly attributed to Emphysema.  Carvaso G et al 199141 
conducted a study to evaluate the correlation of ECG changes and spirometric 
parameters in corpulmonale secondary to COPD. 
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         They performed the study with 56 patients with COPD and they 
developed an ECG scoring system (0 – 6).  It consists of: 
a. QRS axis > 90o 
b. ‘p’ wave > 2.5 mm 
c. R wave in V1 > 7 mm in R/S in V1 > 1 
d. R/S V5 < or equal to 1 
e. RV strain pattern 
f. RBBB 
         They noted a increased relationship between ECG score and FEV1 / FVC. 
         In our study, the above score study was correlated with FEV1/FVC ratio.  
Patients who had score more than 3 were taken into account.  There is an 
increase correlation between FEV1 / FVC ratio and ECG score system is noted 
i.e. as ECG score increases FEV1 / FVC ratio and increases pressure over load 
on right ventricle. 
         Severe COPD may be complicated by MAT43 (Multifocal Atrial 
Tachycardia).  Significant obstructive airway disease is recognized in 30 – 80% 
of patients presenting with this rhythm abnormality.  In our study MAT has 
been found in 6 patients (12%). 
Arterial Blood Gas 
         Arterial Blood Gas analysis was done for all patients.  Out of 50 patients, 
5 patients showed respiratory acidosis which constitutes 10% of total study 
population; 6% (3) of patients were belonged to severe COPD stage.  4% (2) 
  
 
58  
patients were belonged to moderate COPD stage.  None of the mild COPD 
stage patients showed Arterial Blood Gas abnormality51. 
Echocardiography 
         Right ventricular dilatation, pulmonary hypertension, left ventricle 
systolic function were considered. 
         In this study, out of 50 patients, 4% (2) showed RV dilatation with 
normal LV systolic function.  They were belonged to severe COPD group. 
         According to Pinar Yildiz et al, right ventricular dysfunction directly 
correlated with severity of COPD grading52. 
         With correlation of FEV1 predicted %, arterial blood gas analysis, 
echocardiograpahic changes are prevalent in patients with FEV1 of < 50%53,54. 
         It consistent with Boussuges et al, who demonstrated increase in RV 
diameter in severe COPD with pronounced chronic bronchitis changes and 
arterial hypoxemias57. 
Scope for future study 
 Evaluation of right atrial (RA) strain as reflected by changes in ‘p’ 
wave   amplitude and vector in patients with COPD immediately 
before and after beginning treatment of exacerbations.  As per study 
conducted by Navaid Asad et al, ‘p’ wave amplitude in COPD 
decreases once an acute exacerbation subsides53. 
  
 
59  
 Prognostic role of ECG in CCP (Chronic Corpulmonale) gaiven by 
Antonelli et al54 which includes 
1. S1, S2, S3 pattern 
2. RAO (Rt atrial overload) 
3. RVH 
4. RBBB 
5. Low Voltage QRS 
6. S1 Q3 pattern 
2 of the 6 ECG changes of CCP associated with shorter survival rate 
in COPD patients. 
 Effect of passive smoking or second hand smoke exposure in 
spouses, close contacts of smoking personal by using serum cotinine 
level, urine 4 methyl nitrosamine level.58 
 COPD mortality has increased in recent years and by the year 2020 it 
is expected to become the third leading cause of death in the 
World55.  Hence, further study is required. 
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CONCLUSION 
         From out study of 50 patients of COPD, following conclusions were 
derived. 
1. 60% of patients belonged to predominantly emphysema group 
and 40% belongs to predominantly Chronic Bronchitis group. 
2.  COPD patient mostly were in the age group 4th to 6th decade. 
3. 96% of patients were males. 
4. 70% of COPD patients were from low socio economic status. 
5. History of smoking is present in 88% of the patients. 
6. Family History was present only in 12%. 
7. Radigraphic evidence of pulmonary artery hypertension were 
present in 2%. 
8. Commonest ECG changes were ‘p’ pulmonale pattern (44%). 
9. Multifocal atrial tachycardia in ECG was present in 10% of 
patients. 
10. ABG, Echocardiographic spirometric correlation showed 
respiratory acidosis 4% in moderate COPD; 6% in severe 
COPD patients.  RV dilatation 4% seen in severe grade of 
COPD.  
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PROFORMA 
 
1.  Name      : 
2.  Age      : 
3.  Sex      : 
4.  Occupation     : 
5.  Income       : 
6.  Address      : 
7.  OP / IP No.     : 
8.  Complaints: 
 Breathlessness    :  Duration 
 Cough with expectoration   : 
 Sputum – Amount       : 
 Wt. Loss, Colour loss of appetite  : 
 Fever      : 
 Wheezing     : 
 Diabetes Mellitus, Hypertension  : 
 Any other complaints   : 
9.  Previous History of 
 Cough 
 Smoking – Mod  → > 10/day > 10 Yrs 
         Chain → > 20/day > 15 yrs 
         Wheezing and Asthma 
10. Other relevant past History, family history 
 
11. Clinical findings 
 
 General Examination 
 Chest Findings  
 
12. Investigations 
 
1. TC 
2. DC 
3. ESR 
4. Hb% 
5. Blood Sugar 
 
13. Serum 
 
a. Urea 
b. Creatinine 
c. Electrolytes 
 
14. Urine  
a.   Albumin 
d. Sugar 
e. Deposits 
 
15. Mx test done and positive cases excluded 
 
16. PFT done and those with FEV1 < 70% of FVC are included in study 
 
17. Chest X-ray – AP view / Lateral View 
 
18. Arterial blood gas analysis 
 
19. Cardiovascular status was assessed in all cases along with radiological and 
ECG means to exclude associated disease like Hypertension, valvular heart 
disease, etc., 
 
20. HIV I & II 
